Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes.

about

From Bench to Market: Preparing Human Pluripotent Stem Cells Derived Cardiomyocytes for Various Applications Human Pluripotent Stem Cell-Derived Cardiac Tissue-like Constructs for Repairing the Infarcted Myocardium.Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes.

P2860

Q33847517-799A62F6-3812-455A-928E-2EC8EAEF90BD Q47377047-745BA20E-0754-47DE-8B13-5B1C11D823C9 Q49886492-9D52244D-46B5-4F99-8102-29A191CDC3C4

P2860

Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes.

Item

http://www.wikidata.org/entity/Q41869132

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Recapitulation of Clinical Ind ...... g iPSC-Derived Cardiomyocytes.

@en

type

Item

label

Recapitulation of Clinical Ind ...... g iPSC-Derived Cardiomyocytes.

@en

prefLabel

Recapitulation of Clinical Ind ...... g iPSC-Derived Cardiomyocytes.

@en

P1476

Recapitulation of Clinical Ind ...... g iPSC-Derived Cardiomyocytes.

@en

P2093

Atsushi Nakanishi

http://www.w3.org/2001/XMLSchema#string

Hatsue Furukawa

http://www.w3.org/2001/XMLSchema#string

Hirofumi Nagai

http://www.w3.org/2001/XMLSchema#string

Hiroki Ueda

http://www.w3.org/2001/XMLSchema#string

Ippei Ikushima

http://www.w3.org/2001/XMLSchema#string

Keiji Yamamoto

http://www.w3.org/2001/XMLSchema#string

Koki Nakamura

http://www.w3.org/2001/XMLSchema#string

Kyoko Matsuguma

http://www.w3.org/2001/XMLSchema#string

Makoto Yono

http://www.w3.org/2001/XMLSchema#string

Masanari Shiramoto

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Timing of new black box warnings and withdrawals for prescription medications

A structural basis for drug-induced long QT syndrome

Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes

Modelling the long QT syndrome with induced pluripotent stem cells

Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes

Drug-induced prolongation of the QT interval.

Clinical development success rates for investigational drugs.

Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity

Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes.

P304

226-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.STEMCR.2016.12.014

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28111276

http://www.w3.org/2001/XMLSchema#string

P932

5312248

http://www.w3.org/2001/XMLSchema#string

Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes.

about

P2860

P2860

Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932